BACH2 regulates CD8 + T cell differentiation by controlling access of AP-1 factors to enhancers

Nature Immunology

Volumn 17, Issue 7, 2016, Pages 851-860

  Roychoudhuri, Rahul ^a,b   Clever, David ^a,c   Li, Peng ^d   Wakabayashi, Yoshiyuki ^d   Quinn, Kylie M ^e   Klebanoff, Christopher A ^a   Ji, Yun ^a   Sukumar, Madhusudhanan ^a   Eil, Robert L ^a   Yu, Zhiya ^a   Spolski, Rosanne ^d   Palmer, Douglas C ^a   Pan, Jenny H ^a   Patel, Shashank J ^a,j   Macallan, Derek C ^f   Fabozzi, Giulia ^a   Shih, Han Yu ^g   Kanno, Yuka ^g   Muto, Akihiko ^h,i   Zhu, Jun ^d   Gattinoni, Luca ^a   O'Shea, John J ^g   Okkenhaug, Klaus ^b   Igarashi, Kazuhiko ^h,i   Leonard, Warren J ^d   Restifo, Nicholas P ^a,j   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b BABRAHAM INSTITUTE   (United Kingdom)

^c THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^e NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^f ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^g NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

^h TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ JAPAN AGENCY FOR MEDICAL RESEARCH AND DEVELOPMENT   (Japan)

^j GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN C JUN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR BACH2; UNCLASSIFIED DRUG; BACH2 PROTEIN, MOUSE; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; ONCOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; EFFECTOR CELL; ENHANCER REGION; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; LYMPHOCYTE DIFFERENTIATION; MEMORY CELL; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS IMMUNITY; VIRUS INFECTION; ADAPTIVE IMMUNITY; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; KNOCKOUT MOUSE; LYMPHOCYTE ACTIVATION; METABOLISM; PHYSIOLOGY; VACCINIA; VACCINIA VIRUS; VIROLOGY;

ADAPTIVE IMMUNITY; ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ONCOGENE PROTEIN P65(GAG-JUN); SIGNAL TRANSDUCTION; TRANSCRIPTION FACTOR AP-1; VACCINIA; VACCINIA VIRUS;

EID: 84966603243     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3441     Document Type: Article

References (57)

1. Kaech, S. M. & Cui, W. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12, 749-761 (2012).
2. Belz, G. T. & Kallies, A. Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination. Curr. Opin. Immunol. 22, 279-285 (2010).
3. D'Cruz, L. M., Rubinstein, M. P. & Goldrath, A. W. Surviving the crash: transitioning from effector to memory CD8+ T cell. Semin. Immunol. 21, 92-98 (2009).
4. Williams, M. A. & Bevan, M. J. Effector and memory CTL differentiation. Annu. Rev. Immunol. 25, 171-192 (2007).
5. Restifo, N. P. & Gattinoni, L. Lineage relationship of effector and memory T cells. Curr. Opin. Immunol. 25, 556-563 (2013).
6. Chang, J. T., Wherry, E. J. & Goldrath, A. W. Molecular regulation of effector and memory T cell differentiation. Nat. Immunol. 15, 1104-1115 (2014).
7. Teixeiro, E. et al. Different T cell receptor signals determine CD8+ memory versus effector development. Science 323, 502-505 (2009).
8. Wirth, T. C. et al. Repetitive antigen stimulation induces stepwise transcriptome diversification but preserves a core signature of memory CD8+ T cell differentiation. Immunity 33, 128-140 (2010).
9. Ahmed, R. & Gray, D. Immunological memory and protective immunity: understanding their relation. Science 272, 54-60 (1996).
10. Roychoudhuri, R. et al. Transcriptional profiles reveal a stepwise developmental program of memory CD8+ T cell differentiation. Vaccine 33, 914-923 (2015).
11. Willinger, T., Freeman, T., Hasegawa, H., McMichael, A. J. & Callan, M. F. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J. Immunol. 175, 5895-5903 (2005).
12. Sarkar, S. et al. Functional and genomic profiling of effector CD8 T cell subsets with distinct memory fates. J. Exp. Med. 205, 625-640 (2008).
13. Turner, R. & Tjian, R. Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers. Science 243, 1689-1694 (1989).
14. Glover, J. N. & Harrison, S. C. Crystal structure of the heterodimeric bZIP transcription factor c-Fos-c-Jun bound to DNA. Nature 373, 257-261 (1995).
15. Rincón, M. & Flavell, R. A. AP-1 transcriptional activity requires both T-cell receptor-mediated and co-stimulatory signals in primary T lymphocytes. EMBO J. 13, 4370-4381 (1994).
16. Macián, F., López-Rodríguez, C. & Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 20, 2476-2489 (2001).
17. Kurachi, M. et al. The transcription factor BATF operates as an essential differentiation checkpoint in early effector CD8+ T cells. Nat. Immunol. 15, 373-383 (2014).
18. Li, P. et al. BATF-JUN is critical for IRF4-mediated transcription in T cells. Nature 490, 543-546 (2012).
19. Cippitelli, M. et al. Negative transcriptional regulation of the interferon-promoter by glucocorticoids and dominant negative mutants of c-Jun. J. Biol. Chem. 270, 12548-12556 (1995).
20. Falvo, J. V. et al. Stimulus-specific assembly of enhancer complexes on the tumor necrosis factor-gene promoter. Mol. Cell. Biol. 20, 2239-2247 (2000).
21. Oyake, T. et al. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16, 6083-6095 (1996).
22. Roychoudhuri, R. et al. BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis. Nature 498, 506-510 (2013).
23. Muto, A. et al. Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J. 29, 4048-4061 (2010).
24. Muto, A. et al. The transcriptional programme of antibody class switching involves the repressor Bach2. Nature 429, 566-571 (2004).
25. Hu, G. & Chen, J. A genome-wide regulatory network identifies key transcription factors for memory CD8+ T-cell development. Nat. Commun. 4, 2830 (2013).
26. Kaech, S. M. et al. Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat. Immunol. 4, 1191-1198 (2003).
27. Hikono, H. et al. Activation phenotype, rather than central-or effector-memory phenotype, predicts the recall efficacy of memory CD8+ T cells. J. Exp. Med. 204, 1625-1636 (2007).
28. Boyman, O., Cho, J. H., Tan, J. T., Surh, C. D. & Sprent, J. A major histocompatibility complex class I-dependent subset of memory phenotype CD8+ cells. J. Exp. Med. 203, 1817-1825 (2006).
29. Hendriks, J., Xiao, Y. & Borst, J. CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool. J. Exp. Med. 198, 1369-1380 (2003).
30. Kaech, S. M. & Wherry, E. J. Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection. Immunity 27, 393-405 (2007).
31. Rutishauser, R. L. et al. Transcriptional repressor Blimp-1 promotes CD8+ T cell terminal differentiation and represses the acquisition of central memory T cell properties. Immunity 31, 296-308 (2009).
32. Cui, W. & Kaech, S. M. Generation of effector CD8+ T cells and their conversion to memory T cells. Immunol. Rev. 236, 151-166 (2010).
33. Opferman, J. T. et al. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 426, 671-676 (2003).
34. Sandelin, A., Alkema, W., Engström, P., Wasserman, W. W. & Lenhard, B. JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res. 32, D91-D94 (2004).
35. Rada-Iglesias, A. et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature 470, 279-283 (2011).
36. Shnyreva, M. et al. Evolutionarily conserved sequence elements that positively regulate IFN-expression in T cells. Proc. Natl. Acad. Sci. USA 101, 12622-12627 (2004).
37. Barr, R. K., Kendrick, T. S. & Bogoyevitch, M. A. Identification of the critical features of a small peptide inhibitor of JNK activity. J. Biol. Chem. 277, 10987-10997 (2002).
38. Dong, C. et al. JNK is required for effector T-cell function but not for T-cell activation. Nature 405, 91-94 (2000).
39. Thiel, G., Lietz, M. & Hohl, M. How mammalian transcriptional repressors work. Eur. J. Biochem. 271, 2855-2862 (2004).
40. Russ, B. E. et al. Distinct epigenetic signatures delineate transcriptional programs during virus-specific CD8+ T cell differentiation. Immunity 41, 853-865 (2014).
41. Yoshida, C. et al. Bcr-Abl signaling through the PI-3/S6 kinase pathway inhibits nuclear translocation of the transcription factor Bach2, which represses the antiapoptotic factor heme oxygenase-1. Blood 109, 1211-1219 (2007).
42. Calleja, V., Laguerre, M., Parker, P. J. & Larijani, B. Role of a novel PH-kinase domain interface in PKB/Akt regulation: structural mechanism for allosteric inhibition. PLoS Biol. 7, e17 (2009).
43. Macintyre, A. N. et al. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism. Immunity 34, 224-236 (2011).
44. Kim, E. H. et al. Signal integration by Akt regulates CD8 T cell effector and memory differentiation. J. Immunol. 188, 4305-4314 (2012).
45. Crompton, J. G. et al. Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics. Cancer Res. 75, 296-305 (2015).
46. Muto, A. et al. Activation of Maf/AP-1 repressor Bach2 by oxidative stress promotes apoptosis and its interaction with promyelocytic leukemia nuclear bodies. J. Biol. Chem. 277, 20724-20733 (2002).
47. Gray, S., Szymanski, P. & Levine, M. Short-range repression permits multiple enhancers to function autonomously within a complex promoter. Genes Dev. 8, 1829-1838 (1994).
48. Glasmacher, E. et al. A genomic regulatory element that directs assembly and function of immune-specific AP-1-IRF complexes. Science 338, 975-980 (2012).
49. Okkenhaug, K. Signaling by the phosphoinositide 3-kinase family in immune cells. Annu. Rev. Immunol. 31, 675-704 (2013).
50. Cantrell, D. Protein kinase B (Akt) regulation and function in T lymphocytes. Semin. Immunol. 14, 19-26 (2002).
51. Kim, D. & Salzberg, S. L. TopHat-Fusion: an algorithm for discovery of novel fusion transcripts. Genome Biol. 12, R72 (2011).
52. Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139-140 (2010).
53. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578 (2012).
54. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y. & Greenleaf, W. J. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods 10, 1213-1218 (2013).
55. Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
56. Robinson, J. T. et al. Integrative genomics viewer. Nat. Biotechnol. 29, 24-26 (2011).
57. Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).